EverQuote, Inc. (NASDAQ:EVER – Get Free Report) CTO David Brainard sold 1,097 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $26.47, for a total value of $29,037.59. Following the completion of the sale, the chief technology officer owned 163,030 shares in the company, valued at approximately $4,315,404.10. This represents a 0.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
David Brainard also recently made the following trade(s):
- On Monday, July 6th, David Brainard sold 4,960 shares of EverQuote stock. The stock was sold at an average price of $25.51, for a total value of $126,529.60.
EverQuote Stock Performance
NASDAQ:EVER opened at $25.66 on Friday. EverQuote, Inc. has a 1 year low of $13.88 and a 1 year high of $28.73. The stock has a market cap of $924.53 million, a price-to-earnings ratio of 8.33 and a beta of 0.62. The business has a fifty day moving average of $24.85 and a 200-day moving average of $19.80.
Wall Street Analysts Forecast Growth
A number of analysts have commented on EVER shares. Weiss Ratings upgraded shares of EverQuote from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday. Zacks Research lowered shares of EverQuote from a “hold” rating to a “strong sell” rating in a research note on Friday, August 7th. B. Riley Financial reiterated a “buy” rating and set a $34.00 price objective (up from $30.00) on shares of EverQuote in a research note on Tuesday, August 4th. Wall Street Zen cut EverQuote from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Needham & Company LLC upped their target price on EverQuote from $25.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, August 4th. Six analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $28.17.
View Our Latest Report on EverQuote
Institutional Investors Weigh In On EverQuote
Institutional investors and hedge funds have recently bought and sold shares of the business. Comerica Bank lifted its stake in EverQuote by 235.4% during the third quarter. Comerica Bank now owns 1,100 shares of the company’s stock valued at $25,000 after purchasing an additional 772 shares during the last quarter. Signature Equity Partners LLC boosted its holdings in EverQuote by 65.5% during the first quarter. Signature Equity Partners LLC now owns 2,127 shares of the company’s stock worth $33,000 after buying an additional 842 shares in the last quarter. NewEdge Advisors LLC acquired a new position in EverQuote in the third quarter worth approximately $52,000. Clearstead Advisors LLC grew its position in EverQuote by 70.5% in the fourth quarter. Clearstead Advisors LLC now owns 1,997 shares of the company’s stock worth $54,000 after buying an additional 826 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its holdings in shares of EverQuote by 271.2% in the second quarter. Tower Research Capital LLC TRC now owns 3,259 shares of the company’s stock valued at $79,000 after buying an additional 2,381 shares in the last quarter. 91.54% of the stock is owned by institutional investors and hedge funds.
EverQuote Company Profile
EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.
The company’s core business centers on a quote-comparison engine for personal auto, home, and health insurance products.
Further Reading
- Five stocks we like better than EverQuote
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.
